[EN] ATROPISOMERS OF 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES<br/>[FR] ATROPISOMERES DE DERIVES DE 4-ARYLQUINOLIN-2-ONE SUBSTITUES EN POSITION 3
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2004058260A1
公开(公告)日:2004-07-15
Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives having the general formula wherein R, R1, R2, R3, R4 and R5, are as defined herein, or a non-toxic pharmaceutically acceptable salt, solvate or prodrug thereof. The atropisomers can modulate the large conductance calcium-activated K+ channels and are useful in the treatment of disorders which are responsive to the opening of the potassium channels. In addition, the atropisomers can be stable, i.e., do not interconvert, for periods of up to one month, or more.
具有下列一般式的3-取代-4-芳基喹啉-2-酮衍生物的异构体,其中R、R1、R2、R3、R4和R5如本文所定义,或其无毒药理学上可接受的盐、溶剂化合物或前药。这些异构体可以调节大电导钙激活K+通道,并可用于治疗对开放钾通道有反应的疾病。此外,这些异构体可以稳定,即不会在一个月或更长时间内互相转化。